BioSpace News Archive

Results from the 24-month active treatment study conducted in 31 study centers in Europe and the USA are expected in 2021.

Second Sight Medical Products is a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals

Synlogic (Nasdaq:SYBX) announced today that Caroline Kurtz, Ph.D., Synlogic’s Head of Metabolism, will provide a corporate update at Oppenheimer’s 29th Annual Healthcare Conference at 3:20 pm ET on Wednesday, March 20, 2019, in New York City.

Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA

Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that, due to the public offering of common stock announced on March 12, 2019

Health Canada is advising Canadians that Pro Doc Limitée is voluntarily recalling two lots of irbesartan tablets because of a nitrosamine impurity, N-nitrosodiethylamine.

To help customers with an accelerated route to market for 3D printed PAEK parts, UK-based Victrex has commenced a multi-million Euro investment in Bond High Performance 3D Technology.

Leonhardt’s Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup accelerator focused on bioelectric and biologics based organ regeneration and recovery, today announced filing of patent application for bioelectrical stimulation signaling sequences able to control the release of Klotho,

CRH Medical Corporation, announced its financial and operating results for the year and three months ended December 31, 2018.

BioArctic AB announced that the first clinical study with ABBV-0805 has started in the U.S. AbbVie is responsible for the clinical development of ABBV-0805.